Elekta

Milano, Italy
Milano, Italy
SEARCH FILTERS
Time filter
Source Type

News Article | May 6, 2017
Site: www.prnewswire.com

WIEN, May 6, 2017 /PRNewswire/ -- Elekta Unity (MR-linac) vereint durch intelligentes und richtungsweisendes Design das Beste aus zwei Welten um ein neues Paradigma in der Krebsbehandlung zu schaffen und ein außergewöhnliches Potenzial für schwer zu behandelnde Krebsarten zu bieten  ...


VIENNA, May 6, 2017 /PRNewswire/ -- Through intelligent and pioneering design, Elekta Unity (MR-linac) combines the best of both worlds to create a new paradigm for cancer care and provide extraordinary potential for 'hard to treat' cancers Today at the 36th ESTRO (European...


VIENNA, May 6, 2017 /PRNewswire/ -- Through intelligent and pioneering design, Elekta Unity (MR-linac) combines the best of both worlds to create a new paradigm for cancer care and provide extraordinary potential for 'hard to treat' cancers Today at the 36th ESTRO (European...


VIENA, May 6, 2017 /PRNewswire/ -- A través de un diseño inteligente y pionero, Elekta Unity (MR-linac) combina lo mejor de ambos mundos para crear un nuevo paradigma en el cuidado del cáncer y ofrecer un extraordinario potencial para tumores difíciles de tratar.     Hoy, en el tri...


WIEN, May 6, 2017 /PRNewswire/ -- Med en intelligent och banbrytande design kombinerar Elekta Unity (MR-linac) det bästa av två världar och skapar helt nya möjligheter för svårbehandlade tumörer.  I dag på den 36:e ESTRO-konferensen (European Society for Radiotherapy &...


Through intelligent and pioneering design, Elekta Unity (MR-linac) combines the best of both worlds to create a new paradigm for cancer care and provide extraordinary potential for 'hard to treat' cancers Today at the 36th ESTRO (European Society for Radiotherapy & Oncology) meeting, Elekta (EKTA-B.ST) introduced Elekta Unity, the only magnetic resonance radiation therapy (MR/RT) system that integrates a premium diagnostic quality (1.5 Tesla) MRI scanner with an advanced linear accelerator and intelligent software. Elekta Unity is expected to deliver precisely-targeted radiation doses while simultaneously capturing the highest-quality MR images, which will allow clinicians to visualize tumors at any time and adapt the treatment accordingly. Members of the Elekta MR-linac Consortium will be at ESTRO 36 to discuss expected clinical applications for the system. To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8094151-elekta-unity-mrt-system-estro-36/ In addition to enabling greater precision in radiation therapy dosing, Elekta Unity will feature several new patient-centric attributes designed to enhance patient comfort during treatment. These features include a compact, wide bore (70cm) MRI, soft tabletop, non-glare room lighting and a table that has a low load height to facilitate ease of patient entry and exit. Elekta Unity is expected to transform the treatment of cancer in several critical ways: "We started the development of an integrated MR-linac system 18 years ago; the presentation of the clinical system is a huge milestone," says Jan Lagendijk, PhD, Professor and Head Radiation Oncology, Department of Radiotherapy / Centre for Image Sciences, University Medical Centre Utrecht, and conceptual architect and inventor of the MR-linac system. "This system will enable tumor dose escalation and extreme normal tissue sparing, it will also enable shorter and more effective treatment regimens, while its ability to perform functional imaging has the potential to perform better dose painting and tumor response assessment." In October 2012, Elekta established a global consortium of partnering institutions to merge precision radiation delivery with MR imaging - from MR technology partner, Philips - in a single system. In addition to assuming responsibility for the core research and development and engineering activities, the consortium has generated the clinical and workflow protocols that will maximize the new system's therapeutic efficacy and ensure seamless integration into existing radiation oncology department procedures. "Elekta Unity is a technical tour de force through which we have overcome the longstanding limitations of operating a radiation delivery system within the high magnetic field of a diagnostic-quality MR imaging system," says Dr. Richard Hausmann, Elekta's President and CEO. "We are pleased to present Elekta Unity to the global oncology community here at ESTRO 36 and recognize this milestone as a testament to the expertise and perseverance of the members of the MR-linac Consortium. Elekta is grateful to all of our partners for their dedication to improving patient care and steadfast commitment to making Elekta Unity a reality." The Elekta Unity is not yet available for general sales in European markets with planned CE Mark for later 2017. Planned commercial availability worldwide to follow the CE Mark issuance. For more information, visit Elekta booth 3000 at ESTRO 36 or http://www.elekta.com/Unity. Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. http://www.elekta.com For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31-653-561-242, e-mail: gert.vansanten@elekta.com Time zone: CET: Central European Time Raven Canzeri, Global Public Relations Manager, Elekta Tel: +1-770-670-2524, e-mail: raven.canzeri@elekta.com Time zone: ET: Eastern Time


News Article | July 24, 2017
Site: en.prnasia.com

THIMPHU, Bhutan, July 24, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has been chosen to deliver the first ever radiation therapy system to the Kingdom of Bhutan. The National Referral Hospital, the largest hospital in the Kingdom, will install an Elekta Compact™ linear accelerator during August, 2017. In modernizing the public health services that it offers its citizens for free, the government of Bhutan will introduce radiation therapy as an essential form of cancer treatment. Today, most of Bhutan's 4,000-5,000 people who are diagnosed with cancer need to travel to Kolkata, India for oncology care. Dr. Viqar Syed, MD (Radiation Oncology), Managing Director of Pinnacle Cancer Centres International, and Dr. S.S. Ray, a Medical Oncologist in Kolkata, were instrumental in the public-private partnership agreement to supply The National Referral Hospital with the Compact system. Dr. Syed says: "The Pinnacle Cancer Centres International has an exemplary leadership of 25 oncologists that will provide the latest oncology education to the Bhutanese doctors and staff." He adds: "Elekta Compact is ideal as a cost-effective introduction to radiation therapy. And with its modular design, the hospital will be able to easily add new functions and features as it expands." Manikandan Bala, Managing Director for Elekta in India says: "We are honored that Bhutan's Ministry of Health has selected our Elekta Compact linear accelerator. Offering advanced radiation treatment at the National Referral Hospital will in itself improve the quality of life of cancer patients. And with Compact's flexibility and dependability, the hospital will meet the government's guarantee of offering affordable and modern health care." The government had stringent requirements when looking for a supplier and device, and Elekta Compact successfully met its environmental impact assessment. Compact is simple to operate, robust and reliable, allowing more patients to be treated quickly and effectively. The Lancet Oncology Commission states in its report, Expanding global access to radiotherapy1, that the economic benefits of investment in radiotherapy are very substantial. Nevertheless, worldwide access to radiotherapy is unacceptably low. The Kingdom of Bhutan is another example of how Elekta is successfully fulfilling its aim to make radiation therapy accessible to more people in low-income and middle-income countries. Learn more about an Elekta Compact™ at www.elekta.com/compact For further information, please contact: Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com This information was brought to you by Cision http://news.cision.com The following files are available for download:


News Article | July 24, 2017
Site: www.prnewswire.com

In modernizing the public health services that it offers its citizens for free, the government of Bhutan will introduce radiation therapy as an essential form of cancer treatment. Today, most of Bhutan's 4,000-5,000 people who are diagnosed with cancer need to travel to Kolkata, India for oncology care. Dr. Viqar Syed, MD (Radiation Oncology), Managing Director of Pinnacle Cancer Centres International, and Dr. S.S. Ray, a Medical Oncologist in Kolkata, were instrumental in the public-private partnership agreement to supply The National Referral Hospital with the Compact system. Dr. Syed says: "The Pinnacle Cancer Centres International has an exemplary leadership of 25 oncologists that will provide the latest oncology education to the Bhutanese doctors and staff." He adds: "Elekta Compact is ideal as a cost-effective introduction to radiation therapy. And with its modular design, the hospital will be able to easily add new functions and features as it expands." Manikandan Bala, Managing Director for Elekta in India says: "We are honored that Bhutan's Ministry of Health has selected our Elekta Compact linear accelerator. Offering advanced radiation treatment at the National Referral Hospital will in itself improve the quality of life of cancer patients. And with Compact's flexibility and dependability, the hospital will meet the government's guarantee of offering affordable and modern health care." The government had stringent requirements when looking for a supplier and device, and Elekta Compact successfully met its environmental impact assessment. Compact is simple to operate, robust and reliable, allowing more patients to be treated quickly and effectively. The Lancet Oncology Commission states in its report, Expanding global access to radiotherapy1, that the economic benefits of investment in radiotherapy are very substantial. Nevertheless, worldwide access to radiotherapy is unacceptably low. The Kingdom of Bhutan is another example of how Elekta is successfully fulfilling its aim to make radiation therapy accessible to more people in low-income and middle-income countries. Learn more about an Elekta Compact™ at www.elekta.com/compact For further information, please contact: Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com This information was brought to you by Cision http://news.cision.com The following files are available for download:


According to the Czech Society for Oncology, more than 73,000 people are diagnosed annually with cancer and almost 27,000 deaths a year are tumor-related. With Versa HD, BulovkaHospital will have the flexibility to treat a broad spectrum of tumors throughout the body, while enabling treatment of highly-complex cancers that require extreme targeting precision. Miloslav Pála, MD, PhD, MBA, Head of the Radiation Oncology department at BulovkaHospital, said: "Elekta was an excellent alternative for this upgrade as it provides competitive solutions that are fully integrated. Versa HD will allow us to treat traditionally challenging cases and with faster treatment times. Together with MOSAIQ and Monaco, we expect better workflows in our department." François Pointurier, Elekta's Senior Vice President for Western and Central Europe, says: "We are very happy that BulovkaHospital has chosen Elekta for its oncology department upgrade. Investing in solutions that can improve efficiency in the clinic and the outcomes of their patients supports the mission of the National Oncological Programme of the Czech Republic: to lower the incidence of cancer, improve quality of life of oncology patients and to rationalize treatment costs of tumor diseases in the Czech Republic." The Versa HD linear accelerators both include Agility, Elekta's high resolution beam shaping solution. Elekta's Flexitron® brachytherapy afterloader together with Oncentra® Brachy treatment planning software are also included in the upgrade. For further information, please contact: Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com. This information was brought to you by Cision http://news.cision.com The following files are available for download:


Blueprint Software, an innovator and global leader in accelerating and de-risking large, complex IT projects, announced today that Elekta, a leading global human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, selected Blueprint as its enterprise platform to manage software requirements as it expands its Agile practices. Elekta knew it needed to modernize its requirements practices by selecting a robust, enterprise scale requirements tool to: "We are very pleased to be supporting Elekta in the very important work that they do,” said Ruth Zive, Vice President of Marketing at Blueprint. "Elekta solutions can, quite literally, save lives, and we look forward to a strong partnership and long lasting relationship to that end." Elekta chose Blueprint as its enterprise requirements management platform because of their robust capabilities for traceability, reuse, and electronic signature, as well as its user friendly and intuitive UX. Elekta is already using the entire spectrum of Blueprint’s capabilities, from requirements definition and traceability to collaboration, use cases, workflows, for both product and customer level requirements. “As people start engaging with Blueprint, they get excited to use it. They definitely see it as superior to our old document-based approach,” said Jeff Hallett, Director, Gobal Process Engineering, Elekta. Elekta also plans to analyze (and measure where appropriate) improvement of productivity, quality, and collaboration with Blueprint in place as its enterprise requirements management solution. By retiring its manual spreadsheet and paper method and replacing it with Blueprint, Elekta will have a simpler, more maintainable electronic requirements management process. With a single shared requirements repository, teams can develop common product definitions and collaborate productively around a shared vision. For more information on how Blueprint is helping accelerate Agile adoption and solution delivery while managing regulatory constraints, please email info(at)blueprintsys(dot)com. Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radio-surgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,600 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: http://www.elekta.com. Blueprint provides industry-leading software solutions that help large organizations build better business applications. Our products – Blueprint, Storyteller and Blueprint Enterprise – resolve many of the time-consuming, costly, and error- prone functions that challenge IT organizations, thus ensuring that mission critical projects are completed successfully, on time and on budget. Organizations across the globe use Blueprint solutions to ensure regulatory compliance, speed transition to Agile, better align business and IT. Nearly half of all Fortune 100 companies choose Blueprint to de-risk and accelerate their software projects. For more information, please visit http://www.blueprintsys.com.

Loading Elekta collaborators
Loading Elekta collaborators